275 related articles for article (PubMed ID: 30776365)
21. Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration.
Renzoni AJ; Peksa GD; DeMott JM
Am J Emerg Med; 2021 Jun; 44():68-71. PubMed ID: 33581603
[TBL] [Abstract][Full Text] [Related]
22. Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Caffrey AR; Morrill HJ; Puzniak LA; LaPlante KL
Clin Ther; 2014 Apr; 36(4):552-9. PubMed ID: 24631473
[TBL] [Abstract][Full Text] [Related]
23. Pharmacist-Driven Methicillin-Resistant
Marinucci V; Louzon PR; Carr AL; Hayes J; Lopez-Ruiz A; Sniffen J
Ann Pharmacother; 2023 May; 57(5):560-569. PubMed ID: 36039495
[TBL] [Abstract][Full Text] [Related]
24. Nosocomial MRSA pneumonia: data from recent clinical trials.
Karvouniaris M; Makris D; Karabekos D; Zakynthinos E
Rev Recent Clin Trials; 2011 Sep; 6(3):235-40. PubMed ID: 21682676
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
Bounthavong M; Hsu DI
Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
[TBL] [Abstract][Full Text] [Related]
26. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Segarra-Newnham M; Church TJ
Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
[TBL] [Abstract][Full Text] [Related]
28. Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.
Rello J; Nieto M; Solé-Violán J; Wan Y; Gao X; Solem CT; De Salas-Cansado M; Mesa F; Charbonneau C; Chastre J
Med Intensiva; 2016 Nov; 40(8):474-482. PubMed ID: 27061776
[TBL] [Abstract][Full Text] [Related]
29. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
Walkey AJ; O'Donnell MR; Wiener RS
Chest; 2011 May; 139(5):1148-1155. PubMed ID: 20864609
[TBL] [Abstract][Full Text] [Related]
30. Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan.
Lin PC; Wang BC; Kim R; Magyar A; Lai CC; Yang YW; Huang YC
J Microbiol Immunol Infect; 2016 Feb; 49(1):46-51. PubMed ID: 26454421
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Alaniz C; Pogue JM
Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
[TBL] [Abstract][Full Text] [Related]
32. Methicillin-resistant
Kiselinova M; Velghe A; Piers R; Verhasselt B; Van Den Noortgate N
Acta Clin Belg; 2019 Dec; 74(6):456-459. PubMed ID: 30444192
[TBL] [Abstract][Full Text] [Related]
33. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ
Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768
[TBL] [Abstract][Full Text] [Related]
34. A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus.
Wang M; Liu X; Tian Z
Trop Med Int Health; 2023 Apr; 28(4):315-323. PubMed ID: 36852899
[TBL] [Abstract][Full Text] [Related]
35. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.
Miyazaki T; Yanagihara K; Kakeya H; Izumikawa K; Mukae H; Shindo Y; Yamamoto Y; Tateda K; Tomono K; Ishida T; Hasegawa Y; Niki Y; Watanabe A; Soma K; Kohno S
J Infect Chemother; 2020 Feb; 26(2):242-251. PubMed ID: 31575499
[TBL] [Abstract][Full Text] [Related]
36. Linezolid Attenuates Lethal Lung Damage during Postinfluenza Methicillin-Resistant Staphylococcus aureus Pneumonia.
Verma AK; Bauer C; Yajjala VK; Bansal S; Sun K
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31383747
[TBL] [Abstract][Full Text] [Related]
37. Rapid MRSA PCR on respiratory specimens from ventilated patients with suspected pneumonia: a tool to facilitate antimicrobial stewardship.
Trevino SE; Pence MA; Marschall J; Kollef MH; Babcock HM; Burnham CD
Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):879-885. PubMed ID: 28004323
[TBL] [Abstract][Full Text] [Related]
38. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
39. Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial.
Collins CD; Schwemm AK
Value Health; 2015 Jul; 18(5):614-21. PubMed ID: 26297089
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Daniel Mullins C; Kuznik A; Shaya FT; Obeidat NA; Levine AR; Liu LZ; Wong W
Clin Ther; 2006 Aug; 28(8):1184-1198. PubMed ID: 16982296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
